Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1.\r\nTo consider and approve the audited financial results for the quarter and the year ended on 31st March, 2025 pursuant to regulation 33 of SEBI (Listed Obligations and Disclosure Requirements) Regulations, 2015;\r\n2.\r\nTo consider any other matter with the permission of the Chairman of the meeting.